BG50389A3 - A process for the production of delta 1,4-3-keto c21-semiester sieroids - Google Patents

A process for the production of delta 1,4-3-keto c21-semiester sieroids

Info

Publication number
BG50389A3
BG50389A3 BG089217A BG8921789A BG50389A3 BG 50389 A3 BG50389 A3 BG 50389A3 BG 089217 A BG089217 A BG 089217A BG 8921789 A BG8921789 A BG 8921789A BG 50389 A3 BG50389 A3 BG 50389A3
Authority
BG
Bulgaria
Prior art keywords
keto
sieroids
semiester
delta
production
Prior art date
Application number
BG089217A
Other languages
Bulgarian (bg)
English (en)
Inventor
Leo Kominek
Holly Wolf
Paula Steiert
Original Assignee
Pharmacia & Upjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company
Publication of BG50389A3 publication Critical patent/BG50389A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/02—Dehydrogenating; Dehydroxylating
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/83—Arthrobacter

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG089217A 1987-03-12 1989-07-17 A process for the production of delta 1,4-3-keto c21-semiester sieroids BG50389A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2512787A 1987-03-12 1987-03-12
PCT/US1988/000405 WO1988007092A1 (en) 1987-03-12 1988-02-19 1,2-dehydrogenation of steroidal 21-esters with a. simplex

Publications (1)

Publication Number Publication Date
BG50389A3 true BG50389A3 (en) 1992-07-15

Family

ID=21824196

Family Applications (1)

Application Number Title Priority Date Filing Date
BG089217A BG50389A3 (en) 1987-03-12 1989-07-17 A process for the production of delta 1,4-3-keto c21-semiester sieroids

Country Status (12)

Country Link
US (1) US5225335A (ko)
EP (1) EP0350488B1 (ko)
JP (1) JP2680870B2 (ko)
KR (1) KR960013094B1 (ko)
AT (1) ATE94212T1 (ko)
AU (1) AU1340888A (ko)
BG (1) BG50389A3 (ko)
DE (1) DE3883973T2 (ko)
DK (1) DK175173B1 (ko)
HK (1) HK153896A (ko)
HU (1) HU204305B (ko)
WO (1) WO1988007092A1 (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1270660B (it) * 1994-10-13 1997-05-07 Poli Ind Chimica Spa Procedimento microbiologico per la preparazione di 3-oxo-4-azasteroidi-17beta-carbossi sostituiti e uso dei prodotti come inibitori dell'enzima 5alfa-riduttasi
AU5873300A (en) * 1999-07-07 2001-01-30 Pharmacia & Upjohn Company Process to prepare exemestane
EP1399463A1 (en) * 2001-06-18 2004-03-24 PHARMACIA & UPJOHN COMPANY PROCESS TO PREPARE 11$g(b),17$g(a),21-TRIHYDROXY-6$g(a)-METHYLPREGNA-1,4-DIENE-3,20-DIONE 21-ACETATE
HU227117B1 (en) 2002-05-10 2010-07-28 Richter Gedeon Nyrt Process for dehydrogenation of aza-androstane compounds
US20090142342A1 (en) * 2006-12-27 2009-06-04 Johns Hopkins University B7-h4 receptor agonist compositions and methods for treating inflammation and auto-immune diseases
KR101591482B1 (ko) 2008-05-28 2016-02-03 레베라겐 바이오파마 인코포레이티드 질환의 치료를 위한 ＮＦ-κＢ 의 비호르몬성 스테로이드 조절제
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
RU2480475C1 (ru) * 2011-11-16 2013-04-27 Российская Федерация, От Имени Которой Выступает Министерство Промышленности И Торговли Российской Федерации Микробиологический способ получения 21-ацетоксипрегна-1,4,9( 11 ),16-тетраен-3,20-диона из 21-ацетоксипрегна-4,9( 11 ),16-триен-3,20-диона
CN103159817A (zh) * 2011-12-13 2013-06-19 辽宁海思科制药有限公司 一种琥珀酸甲泼尼龙的制备方法
CN104650172A (zh) * 2015-03-25 2015-05-27 浙江仙琚制药股份有限公司 琥珀酸甲泼尼龙的制备方法
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2837464A (en) * 1955-01-11 1958-06-03 Schering Corp Process for production of dienes by corynebacteria
US2822318A (en) * 1956-12-07 1958-02-04 Olin Mathieson Production of 3-keto-delta pregnadienes by bacterium cyclo-oxydans
US2902411A (en) * 1957-06-28 1959-09-01 Upjohn Co Use of second steroid to accelerate 1-dehydrogenation of substrate steroid
US2902410A (en) * 1957-09-26 1959-09-01 Upjohn Co Process for the 1,2-dehydrogenation of a steroid with septomyxa
US3360439A (en) * 1964-08-19 1967-12-26 Squibb & Sons Inc Process for preparing 1-dehydro steroids
US3770586A (en) * 1971-03-24 1973-11-06 Upjohn Co Process for the microbiological 1-dehydrogenation of certain 4,9-(11)-pregnadienes
US4524134A (en) * 1982-07-30 1985-06-18 The Upjohn Company Process for preparing 1,2-dehydro steroids
DE3322120A1 (de) * 1982-07-30 1984-02-02 The Upjohn Co., 49001 Kalamazoo, Mich. Verfahren zur umwandlung von 1,2-gesaettigten 3-ketosteroiden in 1,2-dehydrosteroide
US4704358A (en) * 1982-10-25 1987-11-03 The Upjohn Company Δ1 -dehydrogenation with heat or air-dried B. cyclooxidans
US4749649A (en) * 1983-05-16 1988-06-07 The Upjohn Company Microbial Δ1-dehydrogenation process using a scavenger of toxic oxygen

Also Published As

Publication number Publication date
US5225335A (en) 1993-07-06
WO1988007092A1 (en) 1988-09-22
EP0350488A1 (en) 1990-01-17
EP0350488B1 (en) 1993-09-08
HU204305B (en) 1991-12-30
DE3883973D1 (de) 1993-10-14
DK630988A (da) 1988-11-11
JP2680870B2 (ja) 1997-11-19
AU1340888A (en) 1988-10-10
KR960013094B1 (ko) 1996-09-30
KR890700679A (ko) 1989-04-26
HUT50881A (en) 1990-03-28
JPH02502514A (ja) 1990-08-16
DK630988D0 (da) 1988-11-11
HK153896A (en) 1996-08-16
DK175173B1 (da) 2004-06-21
DE3883973T2 (de) 1994-02-17
ATE94212T1 (de) 1993-09-15

Similar Documents

Publication Publication Date Title
BE836672A (fr) Procede de preparation d'acides organiques par hydrolyse biologique
IT7927487A0 (it) Procedimento per la produzione di acidi treo-3-ammino-2-idrossibutanoilammi noacetici nonche' di loro nuovi intermedi.
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
FI802967A (fi) Foerfarande foer framstaellning av fruktsocker
BG50389A3 (en) A process for the production of delta 1,4-3-keto c21-semiester sieroids
NL180098C (nl) Werkwijze ter bereiding van zeer zuiver tereftaalzuur door oxydatie van p-tolualdehyde.
BE836351A (fr) Procede de production d'alcools polyhydroxyles au moyen de ruthenium sur supports argileux
IT1206587B (it) Processo per la produzione di acido acetico.
DE59602236D1 (de) Verfahren zur Herstellung von Ascorbinsäure
ATE156134T1 (de) Verfahren zur herstellung von alkylpolyglukosiden
UA8357A1 (uk) Спосіб оптичного поділу піранобензоксадіазольної сполуки
ATE116636T1 (de) Verfahren zur herstellung von 2,6- dichlordiphenylaminessigsäurederivaten.
FI813289L (fi) Fosfonohydroxiacetonitril foerfarande foer dess framstaellning och dess anvaendning som mellanprodukt vid framstaellning av laekemedel
IT7926964A0 (it) Procedimento per la produzione di derivati dell'acido fenossicarbossilico.
ATE139989T1 (de) Verfahren zur herstellung von niedrigem alkyl-2- oxo-l-gulonat
RU95108602A (ru) Способ получения динитротолуола
TW332205B (en) A process for making a clinically efficacious HIV protease inhibitor eliminates one step in its synthesis, by an alternative convergent synthesis using 2(S)-4-picolyl-2-piperazine-t-butyl-carboxamide as an intermediate.
IT8025223A0 (it) Procedimento per la produzione di derivati dell'acido penicillanico.
SE7601948L (sv) Sett att framstella karboxi-alkan-fosfonsyror och karboxi-alkyl-fosfinsyror
DE69020377D1 (de) Verfahren zur Herstellung von für die Umwelt unbedenklichem Dicofol und dessen Formulierungen.
ATE12391T1 (de) Verfahren zur herstellung von tetronsaeure.
JPS5223037A (en) Process for preparation of optical active amino acid
IT7823805A0 (it) Metodo per migliorare la promozione di un processo catalitico per laproduzione di alcoolici poliossidrilici.
IT7820346A0 (it) Processo per la preparazione di esteri di acidi bis-(3',5'-di-t-butil-4'-idrossi-fe nil)alchilcarbossilici.
JPS53112868A (en) Production of thienylacetic acid derivative